Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The meningococcus tamed?

A J Pollard1, E R Moxon

  • 1Oxford Vaccine Group, Department of Paediatrics, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK. andrew.pollard@paediatrics.ox.ac.uk

Archives of Disease in Childhood
|June 29, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.

NPJ vaccines·2025
Same author

Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology.

The Journal of infection·2024
Same author

A Retrospective Service- Evaluation of Implant Success, Survival, Periimplant Health and Prosthetic Complications in a Cohort of Head and Neck Cancer Patients.

The European journal of prosthodontics and restorative dentistry·2022
Same author

Metal hyperaccumulation: a model system for coevolutionary studies.

The New phytologist·2021
Same author

Cracked Tooth Syndrome: Assessment, Prognosis and Predictable Management Strategies.

The European journal of prosthodontics and restorative dentistry·2021
Same journal

Radical overhaul needed for children's hearing services could start with the management of glue ear.

Archives of disease in childhood·2026
Same journal

Protecting adolescent confidentiality in the digital age: a global call for adolescent-informed electronic health records.

Archives of disease in childhood·2026
Same journal

Diagnostic accuracy study assessing the ability of paediatric asthma scores to predict admission following initial emergency department bronchodilator therapy: a Clinical Asthma Scoring systems in Paediatric Emergency (CASPER) study.

Archives of disease in childhood·2026
Same journal

Artificial intelligence for child health: current capabilities and the next frontier.

Archives of disease in childhood·2026
Same journal

Troubled origins and lasting impact of the first insulin injection.

Archives of disease in childhood·2026
Same journal

Paediatric readiness assessment tools in emergency care: a scoping review.

Archives of disease in childhood·2026
See all related articles

Serogroup B Neisseria meningitidis causes frequent invasive disease, but current vaccines have limited efficacy in children. This review explores research and new strategies for developing effective serogroup B vaccines.

Area of Science:

  • Microbiology
  • Vaccinology
  • Immunology

Background:

  • Serogroup B Neisseria meningitidis is a leading cause of invasive meningococcal disease globally.
  • Current vaccines show limited efficacy in children under 4 years old, necessitating new approaches.

Purpose of the Study:

  • To review the current research landscape for Serogroup B Neisseria meningitidis vaccines.
  • To explore novel strategies for developing effective vaccines against Serogroup B meningococcal disease.

Main Methods:

  • Literature review of existing research on meningococcal vaccines.
  • Analysis of current challenges and emerging technologies in vaccine development.

Main Results:

  • Existing outer membrane vesicle vaccines have shown limited efficacy in young children.

Related Experiment Videos

  • Several promising new vaccine candidates and approaches are under investigation.

    • Conclusions:

    • There is a critical need for effective Serogroup B Neisseria meningitidis vaccines for routine immunization.
    • Continued research and development of novel vaccine strategies are essential to combat invasive meningococcal disease.